Rhythm AI

San Francisco, United States Founded: 2018 • Age: 8 yrs
AI-based platform for cardiac disease diagnosis is provided.

About Rhythm AI

Rhythm AI is a Healthcare company based in San Francisco (United States) founded in 2018 by Richard Schilling, Ross Hunter, and Shohreh Honarbakhsh. AI-based platform for cardiac disease diagnosis is provided. Rhythm AI has raised $2.65 million across 1 funding round from investors including Rinkelberg Capital. The company has 3 employees. Rhythm AI offers products and services including STAR Apollo Mapping System. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its competitors include Fifth Eye and Elucid; 2 of its 2 listed competitors have raised funding.

Company details

Rhythm AI provides an AI-based platform for the diagnosis of cardiac disease. The platform STAR Mapping is an AI technology used in catheter ablation of AF that replicates the logical, deductive, process applied to electrical signals, which are collected by the cardiac catheters already used in the mapping procedure.

  • Headquarters San Francisco, United States
  • Employees 3
  • Founders Richard Schilling, Ross Hunter, Shohreh Honarbakhsh
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website rhythm-ai.com
  • Social LinkedIn
Key Metrics
  • Total Equity Funding
    $2.65M (USD)

    in 1 rounds

  • Latest Funding Round
    $2.65M (USD), Seed

    Sep 2019

  • Investors
  • Employee Count
    3

Products & Services of Rhythm AI

Rhythm AI offers a comprehensive portfolio of products and services, including STAR Apollo Mapping System.

STAR Apollo Mapping System
AI Medical Software

Analyzes electrophysiology data to identify arrhythmia patterns for treatment.

Funding Insights of Rhythm AI

Rhythm AI has successfully raised a total of $2.65M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.65 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $2.65M
  • Total Rounds 1
  • Last Round Seed β€” $2.65M
  • First Round $2.65M

    (Sep 2019)

  • Investors Count 1

All 1 funding rounds of Rhythm AI with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2019$2.65MSeed––
Valuation history

1 investors in total: 1 institutional.

Investors in Rhythm AI

Rhythm AI has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Rinkelberg Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Private equity fund focused on multiple sectors
rinkelberg.comLondon, United Kingdom
Premium access

Investor details for Rhythm AI

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Rhythm AI

11 people are tracked at Rhythm AI (8 in leadership, 3 in team); the tracked headcount is 3.

NameRoleGroup
Richard Schilling
Co-FounderLeadership
Ross Hunter
Co-FounderLeadership
Shohreh Honarbakhsh
Co-FounderLeadership
Xinwei Shi
CTOLeadership
Simon Hubbert
Founder & CEOLeadership
Ian Ardill
CFOLeadership
Malcolm Finlay
Chief Scientific OfficerLeadership
Linda D’abate
VP, Regulatory & Clinical Affairs & QualityLeadership
Keya Patel
Field Clinical SpecialistTeam
Jeff Schultz
Senior Field Clinical ManagerTeam
Thomas Butler
CISOTeam
Premium access

Complete people profiles for Rhythm AI

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Rhythm AI

2 dated milestones of Rhythm AI across 1 years, from founding to its latest funding, stage changes and deals.

  1. Founded Rhythm AI is founded.
  2. Funding First funding round of $2.6M.

Competitors of Rhythm AI

Rhythm AI has 2 listed competitors in our database, 2 of them funded. They include Fifth Eye and Elucid.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
fiftheye.com2017Ann Arbor, United States$19.3M13
An analytics platform for managing hemodynamic instability is provided.
elucid.com2013Boston, United States$151.87M28
AI-based arterial analysis software is developed for clinical providers.
Premium access

Detailed competitors of Rhythm AI

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Rhythm AI

The website of Rhythm AI (rhythm-ai.com) receives about 1.4K visits a month.

  • Monthly visits
    1.4K

    ▲ 6.5% vs previous month

Similar websites

Websites whose visitors overlap most with Rhythm AI. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
rhythms.ai
100%
10.7K#1,830,436View details

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as Rhythm AI (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Rhythm Ai

Premium access

Complete news archive for Rhythm AI

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rhythm AI

Rhythm AI was founded in 2018 and raised its 1st funding round 1 year after it was founded.

Rhythm AI is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Rhythm AI is a funded company, having raised a total of $2.65M across 1 funding round to date. The company's 1st funding round was a Seed of $2.65M, raised on Sep 2019.

Rhythm AI has 3 employees.

Rhythm AI provides an AI-based platform for the diagnosis of cardiac disease. The platform STAR Mapping is an AI technology used in catheter ablation of AF that replicates the logical, deductive, process applied to electrical signals, which are collected by the cardiac catheters already used in the mapping procedure.

Rhythm AI's top competitors include Elucid and Fifth Eye.

Rhythm AI offers STAR Apollo Mapping System.

Rhythm AI has 1 investor. Key investors include Rinkelberg Capital.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available